Dyne Therapeutics Inc. (DYN) NASDAQ

$7.30 -0.45 (-5.81%)

Market Cap: $376.16M

As of 01/20/22 04:00 PM EST. Market closed.

(DYN)

Dyne Therapeutics Inc. (DYN) NASDAQ

$7.30 -0.45 (-5.81%)

Market Cap: $376.16M

As of 01/20/22 04:00 PM EST. Market closed.

Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United ... read more

Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United States. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$950,000
CEO Compensation (Total)
$6.94M
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
47
CEO Compensation (Base)
$950,000
CEO Compensation (Total)
$6.94M
Address
.
KEY STATS
Open
$7.97
Previous Close
$7.75
Days Range
$7.24 - $8.06
52 week range
$7.24 - $22.92
Volume
230,782
Avg. Volume (30 days)
268,517
Market Cap
$376.16M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
51,528,469
Open
$7.97
Previous Close
$7.75
Days Range
$7.24 - $8.06
52 week range
$7.24 - $22.92
Volume
230,782
Avg. Volume (30 days)
268,517
Market Cap
$376.16M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
51,528,469

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR DYNE THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
HIGH SUSANNA GATTI Chief Operating Officer Sep 23, 2021 Sale $17.22 2,451 42,206 33,453 Sep 24, 2021, 10:50 AM
Scalzo Richard William See Remarks Sep 21, 2021 Sale $16.11 492 7,926 10,606 Sep 22, 2021, 08:03 PM
Scalzo Richard William See Remarks Sep 20, 2021 Sale $15.61 367 5,729 11,098 Sep 22, 2021, 08:03 PM
McNeill Jonathan See Remarks Sep 20, 2021 Sale $15.61 545 8,507 36,365 Sep 22, 2021, 08:02 PM
McNeill Jonathan See Remarks Sep 21, 2021 Sale $16.11 729 11,744 35,636 Sep 22, 2021, 08:02 PM
Brumm Joshua T See Remarks Sep 21, 2021 Sale $16.11 4,584 73,848 99,018 Sep 22, 2021, 08:02 PM
Brumm Joshua T See Remarks Sep 20, 2021 Sale $15.61 3,425 53,464 103,602 Sep 22, 2021, 08:02 PM
Beskrovnaya Oxana Chief Scientific Officer Sep 20, 2021 Sale $15.61 617 9,631 18,672 Sep 22, 2021, 08:01 PM
Beskrovnaya Oxana Chief Scientific Officer Sep 21, 2021 Sale $16.11 827 13,323 17,845 Sep 22, 2021, 08:01 PM
VV Manager II, LLC 10% Owner Sep 21, 2020 Buy $19.00 22,005 418,095 79,921 Sep 23, 2020, 07:11 PM
VV Manager II, LLC 10% Owner Sep 21, 2020 Buy $19.00 792,995 15,066,905 2,880,125 Sep 23, 2020, 07:11 PM
Logos Global Management LP 10% Owner Sep 21, 2020 Buy $19.00 700,000 13,300,000 1,504,392 Sep 23, 2020, 07:09 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Sep 21, 2020 Buy $19.00 660,000 12,540,000 2,805,045 Sep 23, 2020, 06:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
HIGH SUSANNA GATTI Chief Operating Officer 09/23/2021 42,206
Scalzo Richard William See Remarks 09/21/2021 7,926
Scalzo Richard William See Remarks 09/20/2021 5,729
McNeill Jonathan See Remarks 09/20/2021 8,507
McNeill Jonathan See Remarks 09/21/2021 11,744
Brumm Joshua T See Remarks 09/21/2021 73,848
Brumm Joshua T See Remarks 09/20/2021 53,464
Beskrovnaya Oxana Chief Scientific Officer 09/20/2021 9,631
Beskrovnaya Oxana Chief Scientific Officer 09/21/2021 13,323
VV Manager II, LLC 10% Owner 09/21/2020 418,095
VV Manager II, LLC 10% Owner 09/21/2020 15,066,905
Logos Global Management LP 10% Owner 09/21/2020 13,300,000
RA CAPITAL MANAGEMENT, L.P. 10% Owner 09/21/2020 12,540,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.65%
1Q
09/30/2021
03/31/2021
2.43%
2Q

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.65%
1Q
03/31/2021
2.43%
2Q